Brandinium

Trademark search for:

SIDARIX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2001-07-11 — Application filed
  • 2001-09-05 — Assigned to examiner
  • 2001-09-21 — Final disposition recorded
  • 2002-03-20 — Sec. 1(b) claim deleted
  • 2002-03-20 — Correspondence received in law office
  • 2002-04-24 — Correspondence received in law office
  • 2002-06-09 — Letter of suspension e-mailed
  • 2002-10-08 — Assigned to examiner
  • 2003-05-01 — Inquiry to suspension e-mailed
  • 2003-10-20 — Paper received
  • 2003-10-20 — Correspondence received in law office
  • 2003-11-13 — Case file in ticrs
  • 2003-12-07 — Approved for pub - principal register
  • 2004-01-14 — Notice of publication
  • 2004-02-03 — Published for opposition
  • 2004-04-27 — Registered-principal register
  • 2009-12-03 — Attorney/dom.rep.revoked and/or appointed
  • 2009-12-03 — Teas revoke/app/change addr of atty/dom rep received
  • 2010-05-13 — Teas change of correspondence received
  • 2010-12-03 — Cancelled sec. 8 (6-yr)
  • 2010-12-03 — Final status recorded

Owner Information

GLAXOSMITHKLINE BIOLOGICALS S.A.
RIXENSART BE
SmithKline Beecham Biologicals S.A.
Rixensart BE
SmithKline Beecham Biologicals S.A.
Rixensart BE
SmithKline Beecham Biologicals S.A.
Rixensart BE

Correspondent

Maribeth Day Case (who was appointed attorney on o GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park, NC 27709

Filing Details

Filing Date:
2001-07-11
Status Date:
2010-12-03
Category:
Pharmaceuticals
Filing Year:
2001

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.